“Purchaser further acknowledges that the long-term effects and efficacy of the Vaccine are not currently known and that there may be adverse effects of the Vaccine that are not currently known.”

• • •

08/06/21

Leaked Document Reveals ‘Shocking’ Terms of Pfizer’s International Vaccine Agreements

Vaccine purchasers must “indemnify, defend and hold harmless Pfizer … from and against any and all suits, claims, actions, demands, losses, damages, liabilities, settlements, penalties, fines, costs and expenses … arising out of, relating to, or resulting from the vaccine.”

Vaccine makers have nothing to lose by marketing their experimental COVID-19 shots, even if they cause serious injury and death, as they enjoy full indemnity against injuries occurring from COVID-19 vaccines or any other pandemic vaccine under the Public Readiness and Emergency Preparedness (PREP) Act, passed in the U.S. in 2005.

The full extent of their COVID-19 vaccine indemnification agreements with countries, however, is a closely guarded secret, one that has remained highly confidential — until now. A leaked document broken down by Twitter user Ehden reveals the shocking terms of Pfizer’s international COVID-19 vaccine agreements. …

“These agreements are confidential, but luckily one country did not protect the contract document well enough, so I managed to get a hold of a copy,” he wrote. “As you are about to see, there is a good reason why Pfizer was fighting to hide the details of these contracts.”

An ironclad agreement, all on Pfizer’s terms

The alleged indemnification agreement, reportedly between Pfizer and Albania, was originally posted in snippets on Twitter, but Twitter now has them marked as “unavailable.” Copies of the tweets are available on Treadreader, however.

The Albania agreement appears very similar to another contract, published online, between Pfizer and the Dominican Republic. It covers not only COVID-19 vaccines, but any product that enhances the use or effects of such vaccines.

Countries that purchase Pfizer’s COVID-19 shot must acknowledge that “Pfizer’s efforts to develop and manufacture the Product” are “subject to significant risks and uncertainties.”

And in the event that a drug or other treatment comes out that can prevent, treat or cure COVID-19, the agreement stands, and the country must follow through with their order. Ivermectin, for instance, is not only safe, inexpensive and widely available but has been found to reduce COVID-19 mortality by 81%. Yet, it continues to be ignored in favor of more expensive, and less effective, treatments and mass experimental vaccination. …

The big secret: Pfizer charged U.S. More Than Other Countries

While COVID-19 vaccines are “free” to receive in the U.S., they’re being paid for by taxpayer dollars at a rate of $19.5011 per dose. Albania, the leaked contract revealed, paid $12 per dose, while the EU paid $14.70 per shot. While charging different prices to different purchases is common in the drug industry, it’s often frowned upon. …

Safety and efficacy ‘not currently known’

The purchaser of Pfizer’s COVID-19 vaccine must also acknowledge two facts that have largely been brushed under the rug: Both their efficacy and risks are unknown. According to section 5.5 of the contract:

“Purchaser acknowledges that the Vaccine and materials related to the Vaccine, and their components and constituent materials are being rapidly developed due to the emergency circumstances of the COVID-19 pandemic and will continue to be studied after provision of the Vaccine to Purchaser under this Agreement.

“Purchaser further acknowledges that the long-term effects and efficacy of the Vaccine are not currently known and that there may be adverse effects of the Vaccine that are not currently known.”

STORY